Optimark and Colitis - a phase IV clinical study of FDA data

Summary:

Colitis is reported as a side effect among people who take Optimark (gadoversetamide), especially for people who are male, 50-59 old, have been taking the drug for < 1 month also take Magnevist, and have High blood pressure.

The phase IV clinical study analyzes which people have Colitis when taking Optimark. It is created by eHealthMe based on reports of 3,054 people who have side effects when taking Optimark from the FDA, and is updated regularly.

What is Optimark?

Optimark has active ingredients of gadoversetamide. eHealthMe is studying from 3,055 Optimark users. Check the latest studies of Optimark.

What is Colitis?

Colitis (inflammation of colon) is found to be associated with 1,608 drugs and 1,520 conditions by eHealthMe. Check the latest studies of Colitis.

On Jan, 14, 2026

3,054 people reported to have side effects when taking Optimark.
Among them, 7 people (0.23%) have Colitis.

Among these 7 people:

How long have people been on Optimark when they have Colitis? *

What is the gender of people who have Colitis when taking Optimark? *

female: 50 %
male: 50 %

What is the age of people who have Colitis when taking Optimark? *

What are other drugs people take besides Optimark? *

Magnevist: 6 people, 85.71%
Omniscan: 4 people, 57.14%
Multihance: 4 people, 57.14%
Prednisone: 4 people, 57.14%
Prograf: 4 people, 57.14%
Clonidine: 3 people, 42.86%
Midodrine Hydrochloride: 2 people, 28.57%
Xalatan: 2 people, 28.57%
Myfortic: 2 people, 28.57%
Omnipaque 140: 2 people, 28.57%

What are other side effects people have besides Colitis? *

Nephrogenic Systemic Fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease): 7 people, 100.00%
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 3 people, 42.86%
Herpes Zoster: 3 people, 42.86%
Osteomyelitis (infection of bone): 2 people, 28.57%
Oedema Peripheral (superficial swelling): 2 people, 28.57%
Ocular Icterus (presence of jaundice seen in the sclera of the eye): 2 people, 28.57%
Occult Blood Positive: 2 people, 28.57%
Neuropathy Peripheral (surface nerve damage): 2 people, 28.57%
Pain: 2 people, 28.57%
Hypophosphataemia (electrolyte disturbance in which there is an abnormally low level of phosphate in the blood): 2 people, 28.57%

What are the existing conditions these people have? *

Pain: 3 people, 42.86%
High Blood Pressure: 3 people, 42.86%
Sleep Disorder: 2 people, 28.57%
Nuclear Magnetic Resonance Imaging Brain: 2 people, 28.57%
Fibromyalgia (a long-term condition which causes pain all over the body): 2 people, 28.57%
Eye Disorder: 2 people, 28.57%
Diabetes: 2 people, 28.57%
Acute Kidney Failure: 1 person, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Optimark and have Colitis?

- Check whether Colitis is associated with a drug or a condition (FREE)
- Predict drug outcomes for up to one year with AI (FREE)
- Get an AI agent to monitor your drugs continuously (FREE)

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Optimark:

Optimark (3,055 reports)

Colitis treatments and more:

Colitis (53,788 reports)

Browse all side effects of Optimark:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Colitis:

Colitis (1,609 drugs)

Browse all the conditions that are associated with Colitis:

Colitis (1,520 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on gadoversetamide (the active ingredients of Optimark) and Optimark (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.